What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physicians

被引：3
|
作者：
Massie, BM [1 ]
机构：
[1] Vet Affairs Med Ctr, Cardiol Sect, San Francisco, CA 94121 USA
来源：
JOURNAL OF CARDIAC FAILURE | 2002年 / 8卷 / 04期
关键词：
D O I：
10.1054/jcaf.2002.127612
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：197 / 201
页数：5
相关论文
共 50 条
  • [31] The interaction between aspirin and losartan on cardiovascular morbidity and mortality in patients with hypertension and left ventricular hypertrophy. A losartan intervention for endpoint reduction (LIFE) substudy
    Fossum, E
    Kjeldsen, SE
    Dahlof, B
    Devereux, RB
    Julius, S
    Snapinn, S
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 11A - 12A
  • [32] The interaction between aspirin and losartan on cardiovascular morbidity and mortality in patients with hypertension and left ventricular hypertrophy.: A losartan intervention for endpoint reduction (life) substudy
    Fossum, E
    Kjeldsen, SE
    Dahlöf, B
    Devereux, RB
    Julius, S
    Snappin, S
    JOURNAL OF HYPERTENSION, 2003, 21 : S118 - S118
  • [33] Left atrial size and risk of major cardiovascular events during antihypertensive treatment -: Losartan intervention for endpoint reduction in hypertension trial
    Gerdts, Eva
    Wachtell, Kristian
    Omvik, Per
    Otterstad, Jan Erik
    Oikarinen, Lasse
    Boman, Kurt
    Dahlof, Bjorn
    Devereux, Richard B.
    HYPERTENSION, 2007, 49 (02) : 311 - 316
  • [34] Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy -: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
    Gerdts, E
    Oikarinen, L
    Palmieri, V
    Otterstad, JE
    Wachtell, K
    Boman, K
    Dahlöf, B
    Devereux, RB
    HYPERTENSION, 2002, 39 (03) : 739 - 743
  • [35] Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study
    Kjeldsen, Sverre E.
    Devereux, Richard B.
    Hille, Darcy A.
    Lyle, Paulette A.
    Dahlof, Bjorn
    Julius, Stevo
    Edelman, Jonathan M.
    Snapinn, Steven M.
    De Faire, Ulf
    Fyhrquist, Frej
    Ibsen, Hans
    Lederballe-Pedersen, Ole
    Lindholm, Lars H.
    Nieminen, Markku S.
    Omvik, Per
    Oparil, Suzanne
    Wedel, Hans
    BLOOD PRESSURE, 2009, 18 (06) : 348 - 361
  • [36] Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients -: The Losartan Intervention for Endpoint reduction (LIFE) in hypertension study
    Okin, PM
    Devereux, RB
    Jern, S
    Kjeldsen, SE
    Julius, S
    Dahlöf, B
    HYPERTENSION, 2000, 36 (05) : 766 - 773
  • [37] Losartan-based versus atenolol-based therapy in patients with hypertension and left ventricular hypertrophy: An economic evaluation of the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study for Germany
    Krobot, K. J.
    Carides, G. W.
    Wagner, A.
    Burke, T. A.
    VALUE IN HEALTH, 2006, 9 (06) : A353 - A353
  • [38] Cardiovascular morbidity and mortality in patients without pre-existing vascular disease in the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE)
    Devereux, RB
    Dahlof, B
    Kjeldsen, SE
    Julius, S
    Aurup, P
    Beevers, G
    Edelman, J
    de Faire, U
    Fyhrquist, F
    Harris, K
    Ibsen, H
    Kristiansson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Snappin, S
    Wedel, H
    CIRCULATION, 2002, 106 (19) : 475 - 476
  • [39] Change of left ventricular geometric, pattern after 1 year of antihypertensive treatment:: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
    Wachtell, K
    Dahlöf, B
    Rokkedal, J
    Papademetriou, V
    Nieminen, MS
    Smith, G
    Gerdts, E
    Boman, K
    Bella, JN
    Devereux, RB
    AMERICAN HEART JOURNAL, 2002, 144 (06) : 1057 - 1064
  • [40] Change in diastolic left ventricular filling after one year of antihypertensive treatment -: The losartan intervention for endpoint reduction in hypertension (LIFE) study
    Wachtell, K
    Bella, JN
    Rokkedal, J
    Palmieri, V
    Papademetriou, V
    Dahlöf, B
    Aalto, T
    Gerdts, E
    Devereux, RB
    CIRCULATION, 2002, 105 (09) : 1071 - 1076
12345